GlassScriptPhysician profile
Amy Beth Dumais
NPI 1972379360
$1,036.20
in general payments reported to CMS, 2019-2025
16 companies · $461 in 2025
The $461 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $576 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,036.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $316.03 | 2024-2025 | Micra, Linq II |
| Pfizer INC. | $203.11 | 2024-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $91.00 | 2024 | Arcalyst |
| Impulse Dynamics (USA) INC. | $78.71 | 2024 | Optimizer |
| Alnylam Pharmaceuticals INC. | $72.12 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $50.09 | 2024 | Opsumit, Uptravi |
| E.R. Squibb & Sons, L.L.C. | $46.88 | 2024-2025 | Camzyos |
| Novartis Pharmaceuticals Corporation | $28.61 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.37 | 2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $24.33 | 2025 | Wainua |
| Sanofi-Aventis U.S. LLC | $17.67 | 2024 | |
| Convatec INC. | $17.28 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $16.95 | 2024 | |
| Janssen Pharmaceuticals, INC | $16.46 | 2024 | Xarelto |
| Philips North America LLC | $16.18 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $15.41 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Dumais listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.